2004
DOI: 10.1016/j.ejcts.2004.01.054
|View full text |Cite
|
Sign up to set email alerts
|

Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model☆

Abstract: These results suggest that rolipram prevents acute lung injury via the inhibition of neutrophil activation during and after CPB in this setting of a rat model.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0

Year Published

2005
2005
2012
2012

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 18 publications
2
14
0
Order By: Relevance
“…These data are consistent with a previous study (27) that showed an increase in the W/D ratio of the lung and pulmonary edema in a rat CPB model. Our new finding is that this increase in the W/D ratio was attenuated with H2 insufflation.…”
Section: Discussionsupporting
confidence: 95%
“…These data are consistent with a previous study (27) that showed an increase in the W/D ratio of the lung and pulmonary edema in a rat CPB model. Our new finding is that this increase in the W/D ratio was attenuated with H2 insufflation.…”
Section: Discussionsupporting
confidence: 95%
“…Interestingly, rolipram has also been shown to attenuate increased vascular permeability in rodent models attributable ischemia/reperfusion injury (25), cardiopulmonary bypass (26), and high peak inflation pressures (27). When rolipram was administered to intubated, sedated rats before administering thapsigargin, perivascular cuff formation was largely prevented (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Therapeutic effects of PDE4 inhibitors such as rolipram, roflumilast, and cilomilast have been tested in lung injury models. For example, rolipram has been shown to inhibit lung injury and/or inflammation induced by LPS (61), hyperoxia (62), and cardiopulmonary bypass (63). Treatment with roflumilast inhibited lung injury induced by cigarette smoke (64) and bleomycin (65).…”
Section: Phosphodiesterase Inhibitorsmentioning
confidence: 99%